trial · primary record
clonal fetal MSCs
Immune Related Disorder
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 |
| Registry ID | NCT03123458 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:11.579Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03123458
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- clonal fetal MSCs · compound